alpha-aminopyridine has been researched along with Pulmonary Edema in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adewale, AT; Ashtekar, AR; Brand, JD; Harrod, KS; Lazrak, A; Matalon, S; Rowe, SM; Shei, RJ; Tipper, JL; Trombley, JE; Yu, Z | 1 |
Bahra, P; Banner, KH; Dale, N; Freeman, MS; Hardaker, EL; Poll, C; Raza, F | 1 |
Celly, C; Chapman, RW; House, A; Hunter, JC; Jones, H; Lamca, J; Phillips, JE; Prelusky, D; Richard, J; Ting, P | 1 |
3 other study(ies) available for alpha-aminopyridine and Pulmonary Edema
Article | Year |
---|---|
Influenza-mediated reduction of lung epithelial ion channel activity leads to dysregulated pulmonary fluid homeostasis.
Topics: Aminopyridines; Animals; Benzodioxoles; Bronchi; Cells, Cultured; Cystic Fibrosis Transmembrane Conductance Regulator; Disease Models, Animal; Dogs; Epithelial Cells; Epithelial Sodium Channels; Female; Humans; Influenza A virus; Influenza, Human; Madin Darby Canine Kidney Cells; Male; Mice; Primary Cell Culture; Pulmonary Edema; Respiratory Distress Syndrome; Respiratory Mucosa; Sodium-Potassium-Exchanging ATPase; Water-Electrolyte Balance | 2018 |
Exposing rodents to a combination of tobacco smoke and lipopolysaccharide results in an exaggerated inflammatory response in the lung.
Topics: Adrenal Cortex Hormones; Aminopyridines; Animals; Anti-Inflammatory Agents; Benzamides; Bronchoalveolar Lavage Fluid; Budesonide; Cyclopropanes; Disease Models, Animal; Inflammation Mediators; Lipopolysaccharides; Lung; Male; Mucus; Neutrophil Infiltration; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors; Pneumonia; Pulmonary Edema; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Time Factors; Tobacco Smoke Pollution | 2010 |
Effect of inhaled roflumilast on the prevention and resolution of allergen-induced late phase airflow obstruction in Brown Norway rats.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Administration, Inhalation; Aminopyridines; Animals; Anti-Allergic Agents; Benzamides; Bronchoalveolar Lavage Fluid; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclopropanes; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Lung; Ovalbumin; Peak Expiratory Flow Rate; Phosphodiesterase Inhibitors; Pulmonary Edema; Rats; Rats, Inbred BN; Respiratory Hypersensitivity; Time Factors; Vital Capacity | 2007 |